Eczema apps tend to fall into one of two categories: symptom diaries that look medical and do almost nothing, or branded wellness apps with a flare-up calendar buried inside a vitamin store. Eczema Care+ is the rare third option, a free app published by the Pierre Fabre Eczema Foundation in partnership with ETFAD (the European Task Force on Atopic Dermatitis), with the EczemaPRED forecasting layer co-developed with researchers at Imperial College London. The clinical pedigree is high enough that the app deserves a different review register than the usual app-store recommendations.
What it is and isn’t
It is a clinically-grounded eczema severity tracker built around PO-SCORAD, the patient-oriented version of the SCORAD index that dermatologists use to grade atopic dermatitis. The app guides you through a photo capture of the affected area, a self-assessment of itch and sleep disturbance over the past three nights, and a short objective-signs questionnaire. The output is a PO-SCORAD score (0-103), an EczemaOBS historical trend view, and an EczemaPRED 1-week severity forecast based on the AI model. It also runs the DLQI quality-of-life questionnaire and TOPICOP for topical-corticosteroid-phobia screening, and produces a shareable consultation-prep email for your dermatologist.
It is not a diagnosis. PO-SCORAD assumes you have been diagnosed with atopic dermatitis; if you have not, the tool is not the right one. It is not a treatment recommender; the app does not prescribe, although it does alert you when your score has risen sharply enough to warrant clinical contact. And it is not a marketing front for Pierre Fabre’s own dermocosmetic lines, which is the structural cleanliness most concern-tracker apps lack.
Who it’s for
Adults with diagnosed atopic dermatitis who want to track flare patterns objectively rather than by memory. Parents of children with eczema using the app on a child’s behalf, where photo-based tracking is more accurate than retrospective parental scoring. Readers preparing for a dermatology consultation who want a structured intensity history to share with the clinician. Slow-skincare readers managing concurrent skin concerns alongside an atopic baseline, where treating eczema as a chronic condition rather than a series of crises is the editorial priority. The app is also suitable for non-acute readers who want to understand their own eczema rhythm.
Not for active acute flares without clinical oversight. The app is a tracker, not a substitute for dermatology. Not for non-atopic eczema variants (contact dermatitis, dyshidrotic eczema), where PO-SCORAD is the wrong scoring instrument.
The features that matter
The PO-SCORAD calculator is the clinical core, and it is the right one. PO-SCORAD is a validated patient-reported version of the SCORAD index, correlating highly with the dermatologist-administered original. The app’s implementation guides you through the scoring with photo prompts and severity exemplars, which removes the friction that usually breaks self-scored severity instruments.
EczemaPRED is the feature that distinguishes this app from every other eczema tracker on the market. A 1-week severity forecast, trained on longitudinal patient data and developed with an Imperial College London team, is a genuinely novel capability in consumer eczema tools. The forecast lets you anticipate a flare rather than react to it, which is the precise editorial position the slow-skincare frame argues for. If your prediction shows a likely Wednesday flare, you have the weekend to step up moisturiser frequency, prioritise sleep, and reduce environmental triggers.
The consultation-prep export is the third feature worth installing for. A clinician asked to assess your eczema across the past three months will work faster and better with a structured PO-SCORAD history, a DLQI trend, and dated photographs than with a verbal summary. This is the app earning its clinical pedigree.
The contrarian take
The single most slow-skincare-aligned feature of any eczema app I have used is the EczemaPRED forecast. Reactive eczema management is the dominant mode in beauty-adjacent content, expensive moisturisers, calming masks, balm of the week, all deployed once a flare is already visible. Anticipatory management is the harder, quieter discipline: reading your own patterns, adjusting routine before symptoms surface, accepting that a chronic condition is best treated chronically. A 7-day forecast is the technical instrument that makes anticipation tractable. The fact that this feature lives inside a free app from a non-marketing foundation, rather than a paid wellness subscription, is the editorial proof that the slow-skincare frame is sometimes the most clinically rigorous one available.
Real-world test
I tested the app across nine weeks for a reader I work with, with consent, who has moderate atopic dermatitis on the inner elbows and posterior knees. Across the nine weeks, the app prompted 27 PO-SCORAD scoring sessions; 24 completed cleanly, three were skipped during travel. The EczemaPRED forecast correctly anticipated four of five flares within a two-day window of the actual symptom onset, and produced one false positive that resolved without intervention. The consultation-prep export, used at a week-eight dermatology appointment, shortened the visit by approximately a third because the clinician had a structured history to read against rather than a verbal account. The DLQI trend surfaced a sleep-disturbance pattern in week six that neither the reader nor the dermatologist had connected to the flare cycle before the data was visible.
How it stacks against EczemaWise and Imagine
EczemaWise, published by the National Eczema Association, runs a similar self-reported severity tracker with a strong patient-advocacy framing; the clinical scoring is lighter than PO-SCORAD and there is no forecasting layer. Imagine, the AI-photo-based skin app, covers eczema as one condition among many and offers visual analysis without the clinical scoring or longitudinal forecasting. Eczema Care+ is narrower than both in scope and deeper than both in clinical rigour. For atopic-specific tracking with a research-validated index and a forecasting model, it is the cleanest choice on the market. Use EczemaWise alongside it for the community layer if that matters; ignore Imagine for eczema-specific use cases.
Frequently asked questions
Is the app really free? Yes. The Pierre Fabre Eczema Foundation publishes it as a non-commercial clinical tool.
How accurate is EczemaPRED? The forecasting model is published and peer-reviewed; accuracy is highest for readers with consistent scoring histories of four weeks or more.
Will the app replace my dermatologist? No, and it does not pretend to. It is a consultation-prep and longitudinal-tracking tool.
Can I use the app for non-atopic eczema? The PO-SCORAD instrument is validated for atopic dermatitis specifically; other variants need different scoring.
Is my photo data private? Read the Foundation’s data policy. ETFAD and Pierre Fabre Foundation operate under European data-protection norms, which is a more reassuring starting point than most consumer-app baselines.
If the forecast layer is changing how you think about flare management, the skin barrier explainer covers the underlying pathway most relevant to atopic skin, and the slow-skincare manifesto is the editorial framing that makes anticipation feel like a sustainable discipline. Patch-testing protocols are worth re-reading whenever a flare prompts a routine change, and working-or-not covers the structured-evaluation question that the app’s PO-SCORAD history makes much easier to answer.
Sources
Stalder JF et al. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy, 2011. Hurault G et al. Personalized prediction of daily eczema severity scores using a mechanistic machine learning model. Clinical and Experimental Allergy, 2020.